Fredun Pharmaceuticals Ltd — Insider Trading, 31-12-2025: Insider Trading / SAST

Fredun Pharmaceuticals has announced the closure of its trading window for designated persons and their immediate relatives. This measure is effective from January 1st and will remain in place until 48 hours after a forthcoming board meeting. During this meeting, the board will consider, approve, and declare the financial results for the quarter. This standard practice is implemented to prevent insider trading, ensuring fairness and market integrity ahead of key financial disclosures. Shareholders should be aware of this restriction on trading by company insiders.